KEY PRODUCTS
Granules India Limited has high volume world-class facilities for APIs, PFIs, & FDFs, serving customers in over 80 countries.
01 1Granules India Limited
01 1ESOMEPRAZOLE MAGNESIUM DELAYED-RELEASE PELLETS (25.82% W/W)
01 1India
01 1Active
01 1Blank
Granules India Limited has high volume world-class facilities for APIs, PFIs, & FDFs, serving customers in over 80 countries.
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 37233
Submission : 2022-07-01
Status : Active
Type : II
20
Granules India Ltd, based in India, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.
They are recognized for Granules India Limited has high volume world-class facilities for APIs, PFIs, & FDFs, serving customers in over 80 countries.
One of their notable products is ESOMEPRAZOLE MAGNESIUM DELAYED-RELEASE PELLETS (25.82% W/W), with a corresponding US DMF Number 37233.
Remarkably, this DMF maintains an Active status since its submission on July 01, 2022, highlighting commitment to regulatory compliance.
